GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...
OpenAI is seeing a wave of high-profile exits, including Srinivas Narayanan, as leaders and researchers depart amid a ...
Anthropic's valuation hits $800 billion amid U.S. strategic asset recognition. Third best AI model by April 30 at 39.5% YES.
SINGAPORE, SINGAPORE, SINGAPORE, April 17, 2026 /EINPresswire.com/ -- Singapore, April 17, 2026 – The AI landscape in ...
Local AI that actually fits into my day ...
How mature is your AI agent security? VentureBeat's survey of 108 enterprises maps the gap between monitoring and isolation — ...
Learn about the Opus 4.7 update, including its top benchmark scores against ChatGPT 5.4, new tokenizer costs, and advanced ...
The iDX6011 Pro impresses with an easy setup and all the standard NAS options you’d usually expect from a mid-range NAS. The ...
AI doesn’t really “think.” Rather, it remembers how we thought together. And we’re about to stop giving it anything worth ...
The top US frontier labs are in an essential dead heat on the intelligence indexes. Artificial Analysis has released its ...